ClinicalTrials.Veeva

Menu

A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis

D

Duo Zhang

Status

Completed

Conditions

Complication

Study type

Observational

Funder types

Other

Identifiers

NCT01519362
zhangduo

Details and patient eligibility

About

Polyacrylamide hydrogel (PAAG) has been used as an injectable filler for soft tissue augmentation in different parts of the body , such as face, breast , or even penis for more than a decade . However, there are never reports about the application of a large amount of PAAG in epicranial aponeurosis to change the contour of the upper cranium accompanied with leukocytopenia. This fancy application turned out to be a disaster for the women who suffered from leukocytopenia , widespread migration of PAAG, recurrent swelling of the affected tissues and temporal pain changing with the temperature and the facial expression .

Enrollment

1 patient

Sex

Female

Ages

50 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • PAAG injected into bilateral temporal epicranial aponeurosis

Exclusion criteria

  • PAAG injected into other parts of the body

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems